Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Peters

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Important Advances in Oncology|January 1, 1986
Unconventional fractionation schemes in radiotherapyL J Peters, K K Ang
The British Journal of Radiology|September 1, 1975
Letter: Dangers of the clinical use of the NSD formula for small fraction numbersT D Bates, L J Peters
International Journal of Radiation Oncology, Biology, Physics|January 1, 1993
Cellular radiosensitivity as predictors of treatment outcome: where do we stand?L J Peters, W A Brock
The Medical Journal of Australia|January 22, 1972
Haloperidol in radiotherapyK S Mowatt, L J Peters
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.)H R Withers, L J Peters
International Journal of Radiation Oncology, Biology, Physics|July 1, 1999
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapyG M Duchesne, L J Peters
Lancet (London, England)|May 8, 1976
Letter: Levamisole in the treatment of cancerL J Peters, H R Withers
International Journal of Radiation Oncology, Biology, Physics|November 22, 1997
Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factorL J Peters, H R Withers
International Journal of Radiation Oncology, Biology, Physics|March 1, 1983
Dose-response relationship for supraglottic laryngeal carcinomaL J Peters, H D Thames
The Medical Journal of Australia|August 4, 1997
Irradiation for pterygiaD L Ball, L J Peters
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Important Advances in Oncology|January 1, 1986
Unconventional fractionation schemes in radiotherapyL J Peters, K K Ang
The British Journal of Radiology|September 1, 1975
Letter: Dangers of the clinical use of the NSD formula for small fraction numbersT D Bates, L J Peters
International Journal of Radiation Oncology, Biology, Physics|January 1, 1993
Cellular radiosensitivity as predictors of treatment outcome: where do we stand?L J Peters, W A Brock
The Medical Journal of Australia|January 22, 1972
Haloperidol in radiotherapyK S Mowatt, L J Peters
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.)H R Withers, L J Peters
International Journal of Radiation Oncology, Biology, Physics|July 1, 1999
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapyG M Duchesne, L J Peters
Lancet (London, England)|May 8, 1976
Letter: Levamisole in the treatment of cancerL J Peters, H R Withers
International Journal of Radiation Oncology, Biology, Physics|November 22, 1997
Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factorL J Peters, H R Withers
International Journal of Radiation Oncology, Biology, Physics|March 1, 1983
Dose-response relationship for supraglottic laryngeal carcinomaL J Peters, H D Thames
The Medical Journal of Australia|August 4, 1997
Irradiation for pterygiaD L Ball, L J Peters
Pageof 28